Dendritic tau in Alzheimer's disease

Arne Ittner, Lars M. Ittner*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

141 Citations (Scopus)


The microtubule-associated protein tau and amyloid-β(Aβ) are key players in Alzheimer's disease (AD). Aβ and tau are linked in a molecular pathway at the post-synapse with tau-dependent synaptic dysfunction being a major pathomechanism in AD. Recent work on site-specific modification of dendritic and more specifically post-synaptic tau has revealed new endogenous functions of tau that limits synaptic Aβ toxicity. Thus, molecular studies opened a newperspective on tau, placing it at the center of neurotoxic and neuroprotective signaling at the post-synapse. Here, we review recent advances on tau in the dendritic compartments, with implications for understanding and treatment of AD and related neurological conditions.

Original languageEnglish
Pages (from-to)13-27
Number of pages15
Issue number1
Publication statusPublished - 11 Jul 2018


Dive into the research topics of 'Dendritic tau in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this